BRIEF-Coherus Biosciences says PTAB denied 4 petitions for inter partes review of Abbvie's patent
September 07, 2017 at 12:15 PM EDT
* Coherus Biosciences provides update on ‘619 IPR institution decision
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.